Rosiglitazone (Q33684266)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Rosiglitazone	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

Rosiglitazone (English)

1 reference

Europe PubMed Central

28 July 2017

author name string

Balfour JA

1

1 reference

Europe PubMed Central

28 July 2017

Plosker GL

2

1 reference

Europe PubMed Central

28 July 2017

publication date

1 June 1999

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

57

1 reference

Europe PubMed Central

28 July 2017

921-30; discussion 931-2

1 reference

Europe PubMed Central

28 July 2017

6

1 reference

Europe PubMed Central

28 July 2017

https://scigraph.springernature.com/pub.10.2165/00003495-199957060-00007

0 references

Novel euglycemic and hypolipidemic agents. 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPAR-gamma and aP2 in adipose tissue of high-fat-fed rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Up-regulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms and clinical effects of thiazolidinediones

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type 2 diabetes care: the role of insulin-sensitizing agents and practical implications for cardiovascular disease prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Troglitazone: a review of its use in the management of type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance: current concepts

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/10400405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199957060-00007

1 reference

Europe PubMed Central

28 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33684266&oldid=1528830317"